These observations suggest that the contributions of the α2 and α3 subunits to the ASC level in the foetal brain and of the α3 subunit to the adult basal ganglia and cerebellum might be the underlying mechanisms of the pathophysiology of ATP1A3- and ATP1A2-related neurologic disorders. The gene discussed is ATP1A2; the disease is nervous system disorder.